We also found that apoA1 and C3 levels showed a decreasing trend in MCI and sMCI/AD. 3.2.
← all excerpts
Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline.
1
—
—
We also found that apoA1 and C3 levels showed a decreasing trend in MCI and sMCI/AD. 3.2.